IP Library › Granted Patent US 12,724,175
Granted Patent B2
US 12,724,175 · App. 17/978,286 · Granted Sep 1, 2026

Contact lens with optical prophylaxis

Inventors: Mark Acerson (North Logan, UT); David Owen Baumann (Hyrum, UT); Dustin Cefalo (Logan, UT); Frank Chang (Cumming, GA); Peter Haaland (Belmont, MA); Troy Holland (Suwanee, GA); Andrew Ishak (Aberdeen, MD); Raja Gabadage Waruna E. Jinadasa (North Logan, UT); Mark L. Nelson (Midway, UT); Larry Rodriguez (Concord, NC); Adam Sniady (Lilburn, GA); Houliang Tang (Alpharetta, GA); Jiangxing Zhang (Salt Lake City, UT)
Assignee: High Performance Optics, Inc.
G02B1/043C07D487/22G02C7/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,724,175
App. No.
17/978,286
Granted
Sep 1, 2026
Kind
B2
Abstract

The present disclosure provides metalloporphyrin and metallochlorin compounds (e.g., compounds of Formula (II) and (III)), which are useful in the preparation of optical devices (e.g., contact lenses, intraocular lenses, implantable contact lenses) that protect retinal pigment epithelium by the selective blocking of blue light. Also provided are precursor porphyrin and chlorin compounds (e.g., compounds of Formula (I)), and compositions and optical devices incorporating the compounds of the disclosure. Also provided are methods of selecting appropriate metalloporphyrin and metallochlorin compounds for incorporation into optical devices wherein the devices mitigate damage to retinal epithelial cells while balancing changes to luminous transmission, discomfort glare, color distortion, and disruption of circadian rhythms.

Claims (22)

1 . A compound of Formula (I):

or a salt, or tautomer thereof, wherein:

each R is independently hydrogen, halogen, substituted or unsubstituted C 1 -C 20 alkenyl, substituted or unsubstituted C 1 -C 20 alkynyl, or two adjacent R groups, together with the atoms to which they are attached, form a substituted or unsubstituted C 6 -C 14 aryl, substituted or unsubstituted C 5 -C 14 heteroaryl, or substituted or unsubstituted C 3 -C 14 heterocyclyl, or two adjacent R groups are each substituted or unsubstituted C 1 -C 20 alkyl and, together with the atoms to which they are attached, form a substituted or unsubstituted C 3 -C 14 carbocyclyl;

each R 1 is independently hydrogen, halogen, substituted or unsubstituted C 1 -C 20 alkyl, substituted or unsubstituted C 1 -C 20 alkenyl, substituted or unsubstituted C 1 -C 20 alkynyl, or two adjacent R 1 groups, together with the atoms to which they are attached, form a substituted or unsubstituted C 6 -C 14 aryl, substituted or unsubstituted C 3 -C 14 carbocyclyl, substituted or unsubstituted C 5 -C 14 heteroaryl, or substituted or unsubstituted C 3 -C 14 heterocyclyl; or one instance of R 1 and R on the same carbon form with that carbon a carbonyl;

A 1 , A 2 , and A 3 are independently hydrogen or a substituted aryl of formula:

each R 2 is independently hydrogen, halogen, —NO 2 , substituted or unsubstituted alkyl, —NHR A , —N(R A ) 2 , or —OR B ;

is a single or double bond, provided that when is double bond, then each R 1 is absent;

each L is independently:

wherein:

n is 1-6;

each occurrence of R A is independently substituted or unsubstituted C 1 -C 20 alkyl; and

y labels the site with attachment to group X;

each X is independently hydrogen, halogen, substituted or unsubstituted C 1 -C 20 alkyl, or a polymerizable group, provided that at least one X is a polymerizable group; and

each occurrence of R B is independently hydrogen, substituted or unsubstituted acyl, substituted or unsubstituted C 1 -C 20 alkyl, substituted or unsubstituted C 1 -C 20 alkenyl, substituted or unsubstituted C 1 -C 20 alkynyl, substituted or unsubstituted C 3 -C 14 carbocyclyl, substituted or unsubstituted C 3 -C 14 heterocyclyl, substituted or unsubstituted C 6 -14 aryl, or substituted or unsubstituted C 5 -14 heteroaryl.

2 . The compound of claim 1 , or a salt, or tautomer thereof, wherein each R is independently hydrogen, halogen, or two adjacent R groups, together with the atoms to which they are attached, form a substituted or unsubstituted C 3 -C 14 carbocyclyl.

3 . The compound of claim 1 , or a salt, or tautomer thereof, wherein each R 2 is independently hydrogen, —OR B , or halogen.

4 . The compound of claim 1 , or a salt, or tautomer thereof, wherein each X is independently an acrylate, a methacrylate, an acrylamide, a methacrylamide, a styrene, a vinyl sulfone, or alkenyl; wherein each X is substituted or unsubstituted.

5 . The compound of claim 1 , or a salt, or tautomer thereof, wherein each X is independently

6 . The compound of claim 1 , wherein the compound is of Formula (I-a), (I-b), (I-b-1), (I-b-2), (I-b-3), (I-b-4), (I-b-5), (I-b-6), or (I-c):

or a salt, or tautomer thereof.

7 . The compound of claim 1 , wherein the compound is

or a salt or tautomer thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2022
From: ACERSON, MARK; BAUMANN, DAVID OWEN; CEFALO, DUSTIN; CHANG, FRANK; HAALAND, PETER; HOLLAND, TROY; ISHAK, ANDREW; JINADASA, RAJA GABADAGE WARUNA E.; NELSON, MARK L.; RODRIGUEZ, LARRY; SNIADY, ADAM; TANG, HOULIANG; ZHANG, JIANGXING
To: HIGH PERFORMANCE OPTICS, INC.
Reel/Frame 061994/0303 →
Continuity (2)
Provisional Application 63275159 · Nov 3, 2021
Related Publication 20230138968A1 · May 4, 2023
References Cited (39)
US 7022843B1 · MacAlpine et al. · 2006 [cited by applicant]
US 7276544B2 · Lai et al. · 2007 [cited by applicant]
US 7364291B2 · Haywood et al. · 2008 [cited by applicant]
US 7520608B2 · Ishak et al. · 2009 [cited by applicant]
US 7556376B2 · Ishak et al. · 2009 [cited by applicant]
US 8113651B2 · Blum et al. · 2012 [cited by applicant]
US 8360574B2 · Ishak et al. · 2013 [cited by applicant]
US 8882267B2 · Ishak et al. · 2014 [cited by applicant]
US 9063349B2 · Ishak et al. · 2015 [cited by applicant]
US 9377569B2 · Ishak et al. · 2016 [cited by applicant]
US 9683102B2 · Cefalo et al. · 2017 [cited by applicant]
US 9798163B2 · Ishak et al. · 2017 [cited by applicant]
US 9814658B2 · Ishak et al. · 2017 [cited by applicant]
US 10545264B1 · Haaland · 2020 [cited by applicant]
US 10551637B2 · Ishak et al. · 2020 [cited by applicant]
US 10610472B2 · Ishak et al. · 2020 [cited by applicant]
US 10935709B2 · Haaland · 2021 [cited by applicant]
US 11701315B2 · Ishak et al. · 2023 [cited by applicant]
US 11774783B2 · Ishak et al. · 2023 [cited by applicant]
US 20210132416A1 · Newman et al. · 2021 [cited by applicant]
EP 3424688A1 · 2019 [cited by applicant]
WO WO2014189796A1 · 2014 [cited by applicant]
Kralova (J. Med. Chem. 2003, 46, 2049-2056). (Year: 2003). [cited by examiner]
Li (ACS Appl. Mater. Interfaces 2016, 8, 3624-3634). (Year: 2016). [cited by examiner]
Ogawa (Journal of Chemical Research 2020, vol. 44(9-10) 613-617). (Year: 2020). [cited by examiner]
Pechnikova (Russian Journal of General Chemistry, 2016, vol. 86, No. 6, pp. 1505-1509). (Year: 2016). [cited by examiner]
Ozkan (Eur. J. Org. Chem. 2019, 3534â3541). (Year: 2019). [cited by examiner]
Liu (Chem. Eur. J. 2018, 24, 4239 â 4244). (Year: 2018). [cited by examiner]
Brainard et al., Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci. Aug. 15, 2001;21(16):6405-12. doi: 10.1523/JNEUROSCI.21-16-06405.2001. [cited by applicant]
Fekete et al., Spectral discomfort glare sensitivity under low photopic conditions. Ophthalmic Physiol Opt. May 2006;26(3):313-7. doi: 10.1111/j.1475-1313.2006.00359.x. [cited by applicant]
Romney et al., Munsell reflectance spectra represented in three-dimensional Euclidean space. Col Res Appl. Jun. 2003;28(3):182-196. doi: .org/10.1002/col.10144. [cited by applicant]
Taniguchi et al., Database of Absorption and Fluorescence Spectra of >300 Common Compounds for use in PhotochemCAD. Photochem Photobiol. Mar. 2018;94(2):290-327. doi: 10.1111/php.12860. Epub Feb. 13, 2018. [cited by applicant]
Invitation to Pay Additional Fees for Application No. PCT/US2022/048515, mailed Jan. 30, 2023. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2022/048515, mailed Apr. 7, 2023. [cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/US2022/048515, mailed May 16, 2024. [cited by applicant]
Aravindu et al., Synthesis and photophysical properties of chlorins bearing 0-4 distinct meso- substituents. Photochem Photobiol Sci. Dec. 2013;12(12):2089-109. doi: 10.1039/c3pp50240f. [cited by applicant]
Berg et al., Disulfonated tetraphenyl chlorin (TPCS2a), a novel photosensitizer developed for clinical utilization of photochemical internalization. Photochem Photobiol Sci. Oct. 2011;10(10):1637-51. doi: 10.1039/c1pp05… [cited by applicant]
Mosinger et al., Photofunctional polyurethane nanofabrics doped by zinc tetraphenylporphyrin and zinc phthalocyanine photosensitizers. J Fluoresc. Jul. 2009;19(4):705-13. doi: 10.1007/s10895-009-0464-0. Epub Jan. 29, 20… [cited by applicant]
Zhang et al., DFT study on the influence of meso-phenyl substitution on the geometric, electronic structure and vibrational spectra of free base porphyrin. Chemical Physics. 2005;315:201-13. [cited by applicant]